In a groundbreaking achievement, US surgeons at NYU Langone Health have successfully performed the world’s first whole-eye transplant on a human. Despite the patient, Aaron James, not regaining sight in the transplanted eye six months after the 21-hour surgery, the grafted eye shows promising signs of health, including well-functioning blood vessels and a positive-looking retina. Dr. Eduardo Rodriguez, leading the surgical team, emphasized the significant leap forward in the field, as previous transplants were limited to the cornea. While the transplanted eye is not currently connected to the brain, the team injected adult stem cells to encourage optic nerve healing. The groundbreaking procedure opens new possibilities, even if sight restoration isn’t immediate.
Related Posts
The Crucial Link Between Exercise, Youthful Activity, and Blood Pressure Control
- Usama Mudassar
- December 27, 2023
- 0
For those aiming to keep blood pressure in check and reduce the risk of hypertension, especially in midlife, incorporating regular exercise becomes paramount. The research suggested that at least five hours of moderate exercise per week during youth can be instrumental in preventing the heightened risk of high blood pressure in midlife.
Advances in GLP-1 Medications Aim to Enhance Diabetes and Cardiovascular Health
- Usama Mudassar
- June 29, 2024
- 0
GLP-1 agonists are commonly used in medications designed to reduce weight. They mimic the action of GLP-1 hormones, which slow down digestion and increase the feeling of fullness in individuals.
Novo nordisk to supply more wegovy in the U.S. in 2024, shortages to continue.
- Ibtehaj Tahir
- November 4, 2023
- 0
COPENHAGEN (Reuters) – Novo Nordisk, a Danish pharmaceutical company, announced on Thursday that it plans to provide “significantly” more doses of the weight-loss injection Wegovy […]